Applied DNA Sciences (APDN) Financials

$3.09

$0.09 (3.00%)

As on 08-Dec-2025 09:30EDT

Market cap

$7 Mln

Revenue (TTM)

$3 Mln

P/E Ratio

--

P/B Ratio

1.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Operating Revenue	2.14	3.43	13.37	18.17	9.03	1.93
Cost of Revenue	1.30	2.41	7.83	13.12	4.10	0.72
Gross Profit	0.84	1.02	5.53	5.05	4.93	1.21
Operating Expenses	16.89	15.04	16.49	19.02	17.22	13.75
Operating Profit (EBIT)	-16.05	-14.02	-10.95	-13.97	-12.29	-12.54
Other Income	--	--	--	--	--	-0.38
Profit before Tax	-15.64	-7.09	-10.02	-8.27	-14.28	-13.03
Provision for Tax	0.68	0.14	-0.08	0.11	1.75	-0.26
Profit after Tax (Net Income)	-69.49	-6.99	-9.95	-8.38	-16.03	-12.76
Minority Interest	--	0.10	0.08	0.00	-0.01	0.00
Consolidated Profit	--	--	--	-8.38	-14.29	-13.03

Liabilities ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Shareholder's Funds	1.94	9.14	4.95	12.91	11.11	5.72
Minority Interest	--	--	--	--	--	-0.01
Non-Current Liabilities	0.03	1.42	5.93	5.17	0.03	1.37
Current Liabilities	2.46	2.40	2.85	4.19	3.27	4.27
Total Liabilities	4.44	12.79	13.65	22.27	14.42	11.34

Assets ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Non-Current Assets	2.20	4.74	5.53	2.32	3.12	2.26
Current Assets	2.24	8.05	8.13	19.94	11.30	9.08
Total Assets	4.44	12.79	13.65	22.27	14.42	11.34
Total Debt*	0.19	0.74	1.24	--	--	2.35
Net Current Assets	--	5.65	5.28	15.76	8.03	4.81

Cashflow ($ Mln)	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Cash From Operating Activities	-12.24	-13.71	-6.22	-8.98	-13.39	-11.14
Cash Flow from Investing Activities	0.02	-0.41	-1.10	-0.49	-2.55	-1.06
Cash from Financing Activities	--	13.40	0.95	18.13	14.70	19.43
Net Cash Inflow / Outflow	--	--	--	--	--	7.23

Financials Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Adjusted EPS ($)	-121.48	-0.39	-14.66	-14.81	-42.78	-49.67
Cash EPS ($)	-121.48	-0.35	-12.65	-12.53	-40.53	-48.56
Adjusted Book Value ($)	3.39	0.52	7.30	22.82	29.66	22.25
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-21.40	-0.77	-9.17	-15.87	-35.73	-43.36
Free Cash Flow per Share ($)	-21.95	-0.80	-9.28	-16.73	-42.53	-47.50

Profitability Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
ROCE (%)	-1,156.52	-87.02	-104.15	-69.74	-167.16	-291.17
ROE (%)	-1,253.80	-99.23	-111.37	-69.74	-190.46	-523.50
ROA (%)	-806.75	-52.89	-55.39	-45.68	-124.46	-171.27
EBIT Margin (%)	--	-408.72	-81.94	-76.89	-138.76	-648.98
Net Margin (%)	-3,251.74	-203.78	-74.41	-46.11	-177.56	-821.73
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Revenue Growth (%)	-0.38	-0.74	-0.26	1.01	3.67	-0.64
EBIT Growth (%)	--	-28.04	21.59	-11.52	0.06	-48.26
Net Profit Growth (%)	-893.74	29.70	-18.73	47.73	-25.57	-47.87
EPS Growth (%)	-307.24	0.97	0.01	0.65	0.14	0.69
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Price / Earnings	-0.03	-1.65	-0.08	-0.08	-0.13	-0.16
Price / Book Value	1.14	1.26	0.17	0.05	0.18	0.35
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.05	-0.44	0.53	1.15	0.39	0.28
Close Price ($)	3.88	487.28	907.50	847.50	4,042.50	5,797.50
High Price ($)	345.00	3,802.50	2,400.00	5,512.50	10,230.00	14,767.50
Low Price ($)	2.13	165.00	727.50	468.23	3,712.50	1,890.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Debt to Equity	0.10	0.08	0.25	--	--	0.41
Short term debt to equity ratio	0.10	0.12	0.10	--	--	0.32
Current Ratio	0.91	3.36	2.86	4.77	3.45	2.13
Quick Ratio	0.87	3.17	2.74	4.62	3.03	2.01
Interest Coverage	--	--	--	-1.06	-6.31	-108.22

Operating Efficiency Ratios	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16	Sep-15
Debtors to sales (%)	11.11	10.55	1.91	16.88	31.06	10.06
Asset Turnover	0.25	0.26	0.74	0.99	0.70	0.26
Receivable days	51.23	32.87	45.40	59.02	60.65	97.79
Inventory Days	73.54	58.13	21.73	27.46	83.19	162.13
Payable days	328.02	169.26	65.65	43.16	116.06	608.53
Cash Conversion Cycle	-203.26	-78.26	1.48	43.32	27.78	-348.61